Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2005 Oct 20;353(16):1734-6.
doi: 10.1056/NEJMe058196.

Trastuzumab in the treatment of breast cancer

Gabriel N Hortobagyi
Editorial

Trastuzumab in the treatment of breast cancer

Gabriel N Hortobagyi. N Engl J Med. .
No abstract available

PubMed Disclaimer

Comment in

  • Trastuzumab in breast cancer.
    Gounaris IG. Gounaris IG. N Engl J Med. 2006 Feb 9;354(6):640-4; author reply 640-4. N Engl J Med. 2006. PMID: 16470950 No abstract available.
  • Trastuzumab in breast cancer.
    Katsumata M, Drebin JA, Greene MI. Katsumata M, et al. N Engl J Med. 2006 Feb 9;354(6):640-4; author reply 640-4. N Engl J Med. 2006. PMID: 16470952 No abstract available.
  • Trastuzumab in breast cancer.
    Mastrianni DM. Mastrianni DM. N Engl J Med. 2006 Feb 9;354(6):640-4; author reply 640-4. N Engl J Med. 2006. PMID: 16470953 No abstract available.

Comment on

  • Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.
    Piccart-Gebhart MJ, Procter M, Leyland-Jones B, Goldhirsch A, Untch M, Smith I, Gianni L, Baselga J, Bell R, Jackisch C, Cameron D, Dowsett M, Barrios CH, Steger G, Huang CS, Andersson M, Inbar M, Lichinitser M, Láng I, Nitz U, Iwata H, Thomssen C, Lohrisch C, Suter TM, Rüschoff J, Suto T, Greatorex V, Ward C, Straehle C, McFadden E, Dolci MS, Gelber RD; Herceptin Adjuvant (HERA) Trial Study Team. Piccart-Gebhart MJ, et al. N Engl J Med. 2005 Oct 20;353(16):1659-72. doi: 10.1056/NEJMoa052306. N Engl J Med. 2005. PMID: 16236737 Clinical Trial.
  • Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.
    Romond EH, Perez EA, Bryant J, Suman VJ, Geyer CE Jr, Davidson NE, Tan-Chiu E, Martino S, Paik S, Kaufman PA, Swain SM, Pisansky TM, Fehrenbacher L, Kutteh LA, Vogel VG, Visscher DW, Yothers G, Jenkins RB, Brown AM, Dakhil SR, Mamounas EP, Lingle WL, Klein PM, Ingle JN, Wolmark N. Romond EH, et al. N Engl J Med. 2005 Oct 20;353(16):1673-84. doi: 10.1056/NEJMoa052122. N Engl J Med. 2005. PMID: 16236738 Clinical Trial.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

LinkOut - more resources